Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non Substitutive Strategies for Haemophilia in Ivory Coast
NCT03054662Completed
- Start
- Jan 2017
- Primary completion
- Dec 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of desmopressin in hemophilia A and hemophilia B (HB) (2 arms). Primary endpoints: Improve haemophilia care in Ivory Coast at 2 years, Improve haemophilia diagnosis of haemophilia in Ivory Coast at 3 years and 1 more. Started Jan 2017; status: completed.
02
Drugs
desmopressin
03
Conditions
hemophilia Ahemophilia B (HB)
Beyond the preview
Go deeper on NCT03054662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03054662.